Fluoxetine in Individuals with Alcohol Use Disorder and Hepatic Safety

Hepatic Safety Considerations

Naltrexone carries a risk of hepatotoxicity and is not recommended in patients with alcoholic liver disease, according to the Clinical and Molecular Hepatology guidelines 1, 2
Disulfiram should be avoided in advanced alcoholic liver disease due to potential hepatotoxicity, as recommended by the Journal of Hepatology guidelines 3, 4

For alcoholics without advanced liver disease, Disulfiram, naltrexone, or acamprosate combined with counseling is recommended, as suggested by the Journal of Hepatology guidelines 3, 4
For alcoholics with advanced liver disease, Baclofen is safe and effective for preventing relapse, according to the Journal of Hepatology and Clinical and Molecular Hepatology guidelines 1, 3, 4
Brief motivational interventions should be routinely used regardless of medication choice, as recommended by the Journal of Hepatology guidelines 3, 4, 5

When assessing liver function, it is essential to monitor hepatic function given the risk of alcohol-related liver disease, as noted in the Clinical and Molecular Hepatology guidelines 1